Dolby Laboratories, Inc. (DLB) EPS Estimated At $0.65 as of April, 25

Joanna Estrada
April 19, 2018

The institutional investor held 265,618 shares of the multi-sector company at the end of 2017Q4, valued at $16.47M, up from 253,007 at the end of the previous reported quarter. (NYSE:DLB). Geode Cap Mgmt Limited Company invested 0.01% of its capital in Dolby Laboratories, Inc.

Shares of DLB stock traded up $0.43 on Friday, reaching $63.40. Dolby Laboratories, Inc. (NYSE:DLB) has risen 24.18% since April 18, 2017 and is uptrending. It has outperformed by 5.63% the S&P500. (NYSE:DLB). The North Carolina-based Carroll Fincl has invested 0% in Dolby Laboratories, Inc. Edgar Lomax Co sold 36,575 shares as the company's stock declined 10.37% with the market. The hedge fund run by Robert B. Gillam held 177,649 shares of the transportation company at the end of 2017Q4, valued at $23.82 million, down from 269,024 at the end of the previous reported quarter. Renaissance Technologies Llc who had been investing in Riverview Bancorp Inc for a number of months, seems to be bullish on the $213.06 million market cap company. About 224,003 shares traded.

First Quadrant L P CA reduced its stake in Dolby Laboratories, Inc. It has underperformed by 27.43% the S&P500.

Bradley Foster & Sargent Inc decreased Dr Pepper Snapple Group Inc (NYSE:DPS) stake by 7,567 shares to 199,659 valued at $19.38 million in 2017Q4.

Among 6 analysts covering US Foods (NYSE:USFD), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 39% are positive. $2.30M worth of Dolby Laboratories, Inc. $1.07 million worth of Dolby Laboratories, Inc. As per Monday, June 26, the company rating was maintained by Wells Fargo. UBS upgraded the stock to "Buy" rating in Tuesday, September 22 report. On Monday, January 22 the stock of Dolby Laboratories, Inc. Bank of America maintained AT&T Inc. The firm has "Buy" rating given on Wednesday, September 2 by Citigroup. The business is scheduled to issue its next earnings report on Wednesday, April 25th.

Analysts await Copa Holdings, S.A. (NYSE:CPA) to report earnings on May, 9 after the close. They expect $0.87 earnings per share, up 17.57% or $0.13 from last year's $0.74 per share. After $0.78 actual earnings per share reported by AT&T Inc. for the previous quarter, Wall Street now forecasts 11.54% EPS growth.

Big Money Sentiment increased to 1.36 in 2017 Q4. Its down 0.26, from 1.17 in 2017Q3. DLB has 317,802 shares volume. Sold All: 23 Reduced: 68 Increased: 74 New Position: 50. Polar Capital Llp has 1.83M shs for 1.17% of their capital. Wealthtrust owns 618 shares or 0.01% of their United States portfolio. (NYSE:DLB). 25 are owned by Johnson Grp Incorporated. Thompson Davis reported 400 shs stake. Brinker Cap Inc holds 0.02% or 10,047 shares. It also reduced Baxter International Inc (NYSE:BAX) stake by 41,778 shares and now owns 555,385 shares. Pennsylvania-based Private Wealth Advisors has invested 1.12% in AT&T Inc. Moreover, Diversified Investment Strategies Llc has 3.69% invested in the company for 65,725 shares.

Oak Assoc Limited Oh has invested 0.03% in Dolby Laboratories, Inc. For the next fiscal year, analysts anticipate that the firm will report sales of $1.25 billion per share, with estimates ranging from $1.23 billion to $1.27 billion.

Since October 18, 2017, it had 0 insider purchases, and 16 insider sales for $29.07 million activity. Shares for $5.69M were sold by Horgen Jay C. on Wednesday, March 7. Macquarie Group Ltd. now owns 6,300 shares of the electronics maker's stock worth $391,000 after purchasing an additional 5,700 shares during the last quarter.

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. The shares were sold at an average price of $47.60, for a total value of $590,668.40. First Quadrant L P CA's holdings in Dolby Laboratories were worth $18,659,000 as of its most recent SEC filing.

Several equities research analysts recently weighed in on DLB shares. Another trade for 35,866 shares valued at $2.30 million was sold by Baker Giles. (NYSE:DLB) was sold by TEVANIAN AVADIS.

Total analysts of 6 have positions in Dolby Laboratories (NYSE:DLB) as follows: 2 rated it a "Buy", 0 with "Sell" and 4 with "Hold". Therefore 43% are positive. Also, the number of investment managers holding Dolby Laboratories Inc in top ten positions decreased from 4 to 3 for a decrease of 1. Imperial Capital downgraded Copa Holdings, S.A. (NYSE:CPA) on Tuesday, August 4 to "In-Line" rating. (NYSE:DLB) for 76,180 shares. (NYSE:DLB) on Thursday, October 26 with "Buy" rating. JP Morgan maintained Dolby Laboratories, Inc. Piper Jaffray Companies reissued a "hold" rating on shares of Dolby Laboratories in a report on Thursday, January 26th. On Thursday, October 26 the rating was maintained by B. Riley & Co with "Buy". Zacks Investment Research raised shares of Dolby Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, April 6th. (NYSE:DLB) has "Buy" rating given on Wednesday, September 13 by Dougherty. On Thursday, October 19 B. Riley & Co maintained the shares of DLB in report with "Buy" rating. On Tuesday, January 16 the rating was downgraded by B. Riley & Co to "Neutral". On Thursday, January 25 the stock has "Hold" rating by FBR Capital. Contravisory Inv holds 0% in Dolby Laboratories, Inc. (NYSE:DLB). Northern Tru, Illinois-based fund reported 282,208 shs. They expect $0.65 earnings per share, up 38.30% or $0.18 from last year's $0.47 per share. USFD's profit would be $53.90M giving it 34.91 P/E if the $0.25 EPS is correct. -17.72 % negative EPS growth is what analysts predict. $0.79 EPS was revealed for last [previous quarter].

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER